Breaking News
FONT-SIZE Plus   Neg
Share SHARE

Pre-market Movers For April 4 (PSDV, SRPT, CPWR, LULU)

Gainers:

pSivida Corp. (PSDV: Quote) is surging 19 percent to $2.70. The company announced that it has signed a funded technology evaluation agreement with a global pharmaceutical company to evaluate its proprietary Durasert and Tethadur technologies for select products in ophthalmology.

Sarepta Therapeutics, Inc. (SRPT) is up 3 percent to $35.11.

Decliners:

Compuware Corp. (CPWR: Quote) ia falling nearly 4 percent to $11.58 as the company warned that its fourth quarter results would come in way below Wall Street view due to delays in closing a large number of deals. The company also lowered its fiscal year 2013 revenue and earnings outlook.

Lululemon Athletica Inc. (LULU: Quote) is down nearly 1 percent to $63.75. The company announced that its Chief Product Officer Sheree Waterson will be leaving effective April 15. Last month, the company recalled its signature black Luon fabric yoga pants and crops from stores, showrooms and online website due to fabric quality issues.

Click here to receive FREE breaking news email alerts for Lululemon Athletica Inc. and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Editors Pick
This apparel maker has doubled its earnings per share in just two years and increased its annual earnings forecast from time to time, despite a challenging consumer spending environment. Contributions from acquisitions, efficiency gains from self-owned global supply chain and benefits from 'Innovate-to-Elevate' strategy continue to boost the company's results. Here is a quick summary of the earnings reported after the bell on Nov 20. We have 20+ stocks listed here. The good news is you can skip this step. There is a next move that can make your life a lot easier. Our research team has already done the groundwork for you. All these stocks listed... Design software maker Autodesk, Inc. said Thursday after the markets closed that its third quarter profit fell 81% from last year, as higher costs and expenses more than offset an 11% increase in revenue. However, the company's quarterly earnings per share, excluding items, came in above analysts' expectations as did its quarterly revenue.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.